Concentra

Agile Occupational Medicine Expands Leadership Team

Retrieved on: 
星期二, 五月 14, 2024
Professional Services, Health, Practice Management, Physical Therapy, Human Resources, Managed Care, General Health, Partnership, MPH, Occupational medicine, Patient, COVID-19, OCS, Human resources, Translation, Public, Growth, ACGME, Acquisition, DPT, Knowledge, Innovation, Concentra, Management

“Peter’s vast experience as a business transformation executive and leader of our acquisition team was instrumental in our rapid expansion over the last several years,” said Agile Founder and CEO Greg Moore.

Key Points: 
  • “Peter’s vast experience as a business transformation executive and leader of our acquisition team was instrumental in our rapid expansion over the last several years,” said Agile Founder and CEO Greg Moore.
  • “Mike is a dynamic, results-oriented leader who offers visionary leadership and solid operational expertise,” noted Moore.
  • “Agile's executive team now boasts an impressive lineup of seasoned professionals with a wealth of experience in occupational medicine.
  • With these changes to our executive team, Agile is well-positioned to continue its impressive growth trajectory and cement its status as a leader in the occupational health industry.”
    For more information about Agile Occupational Medicine, visit www.agileoccmed.com

Select Medical Holdings Corporation to Announce First Quarter 2024 Results on Thursday, May 2, 2024

Retrieved on: 
星期五, 四月 5, 2024
United, Telephone, Webcast, Select Medical, Concentra

MECHANICSBURG, Pa., April 5, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its first quarter ended March 31, 2024 on Thursday, May 2, 2024 after the market closes.

Key Points: 
  • MECHANICSBURG, Pa., April 5, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its first quarter ended March 31, 2024 on Thursday, May 2, 2024 after the market closes.
  • Select Medical will host a conference call regarding its first quarter results, as well as its business outlook, on Friday, May 3, 2024, at 9:00am ET.
  • The conference call will be a live webcast and can be accessed at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com .
  • At December 31, 2023, Select Medical had operations in 46 states and the District of Columbia.

Intellihealth Hires Annie Lorenzo as Executive VP of Clinical Operations

Retrieved on: 
星期二, 二月 6, 2024
Partnership, Medicaid, Concentra, Human, Obesity, Absenteeism, Physician, Behavior, Acquisition, Health, Practitioner, Organization, Hospital, Nursing

NEW YORK, Feb. 6, 2024 /PRNewswire/ -- Intellihealth, a leading provider of healthcare technology and clinical services that deliver a comprehensive and clinically proven medical model for treating obesity, has hired Annie Lorenzo as executive vice president of clinical operations. Lorenzo will be responsible for providing strategic leadership and day-to-day management of all clinical operations personnel and will play a pivotal role in strengthening the Flyte organization as Intellihealth scales its offerings across the country.

Key Points: 
  • NEW YORK, Feb. 6, 2024 /PRNewswire/ -- Intellihealth , a leading provider of healthcare technology and clinical services that deliver a comprehensive and clinically proven medical model for treating obesity, has hired Annie Lorenzo as executive vice president of clinical operations.
  • Lorenzo will be responsible for providing strategic leadership and day-to-day management of all clinical operations personnel and will play a pivotal role in strengthening the Flyte organization as Intellihealth scales its offerings across the country.
  • "We are delighted to welcome Annie to the Intellihealth team," said Sloan Saunders, Intellihealth CEO.
  • At Babylon, she scaled and led the operations of a large multi-speciality clinical network serving medicaid members in global value-based risk agreements.

Concentra Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Theseus Pharmaceuticals

Retrieved on: 
星期二, 一月 30, 2024
Biotechnology, Pharmaceutical, Health, Oncology, Concentra, CVR, Shareholder, Contingent value rights, Mergers and acquisitions, Amend, Communication, Risk, Acquisition, Schedule, Security (finance)

Pursuant to the Merger Agreement, on January 9, 2024, Purchaser and Parent commenced a tender offer to acquire all outstanding shares of Theseus common stock (the “Offer”).

Key Points: 
  • Pursuant to the Merger Agreement, on January 9, 2024, Purchaser and Parent commenced a tender offer to acquire all outstanding shares of Theseus common stock (the “Offer”).
  • Stockholders that have previously tendered their shares do not need to re-tender their shares or take any other action in response to the determination of the Additional Price Per Share or extension of the Offer expiration date.
  • As previously announced, Theseus stockholders holding approximately 59% of Theseus common stock have signed support agreements to tender their shares in the Offer prior to the expiration date and support the merger.
  • In addition, Theseus’ stockholders may obtain free copies of the Offer materials by contacting Morrow Sodali LLC, the information agent for the Offer.

Select Medical Holdings Corporation to Announce Fourth Quarter and Full Year 2023 Results on Thursday, February 22, 2024

Retrieved on: 
星期一, 一月 22, 2024
Telephone, Select Medical, Concentra, Webcast

MECHANICSBURG, Pa., Jan. 22, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its fourth quarter and full year ended December 31, 2023 on Thursday, February 22, 2024 after the market closes.

Key Points: 
  • MECHANICSBURG, Pa., Jan. 22, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its fourth quarter and full year ended December 31, 2023 on Thursday, February 22, 2024 after the market closes.
  • Select Medical will host a conference call regarding its fourth quarter and full year results, as well as its business outlook, on Friday, February 23, 2024, at 9:00am ET.
  • The conference call will be a live webcast and can be accessed at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com .
  • At December 31, 2023, Select Medical had operations in 46 states and the District of Columbia.

Harlan Law and Hillier DiGiacco LLP Obtain $9.37 Million Verdict Against National Healthcare Conglomerate

Retrieved on: 
星期一, 一月 8, 2024
Motion, Humiliation, Patient, Chronic pain, Hand, Medicine, Arm, SAN, Concentra, Communication, Nursing

This verdict follows more than three years of intensive investigation and litigation, and delivers to Plaintiff Marilyn Buron, long-awaited justice.

Key Points: 
  • This verdict follows more than three years of intensive investigation and litigation, and delivers to Plaintiff Marilyn Buron, long-awaited justice.
  • Marilyn alerted her supervisors at Concentra and took job protected leave from December 1, 2020 through February 22, 2021.
  • According to attorney Jordon Harlan, "At each step of this process, Concentra refused to accept responsibility for violating the law.
  • The jury also awarded $7,810,000 in punitive damages against Concentra to prevent them from ever doing this to anyone again.

THRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Theseus Pharmaceuticals, Inc. Is Fair to Shareholders

Retrieved on: 
星期五, 十二月 22, 2023
Class Action Lawsuit, Professional Services, Legal, Advertising, Fraud, Sale, Concentra

Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) to Concentra Biosciences, LLC for between $3.90 and $4.05 in cash is fair to Theseus shareholders.

Key Points: 
  • Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) to Concentra Biosciences, LLC for between $3.90 and $4.05 in cash is fair to Theseus shareholders.
  • On behalf of Theseus shareholders, Halper Sadeh LLC may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
  • Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.
  • Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Nox Health Expands Board of Directors

Retrieved on: 
星期三, 十一月 1, 2023
Dignity, Fertility, Nox, Telehealth, Obesity, SVP, CommonSpirit Health, Physician, Consultant, Diabetes, Health, Central Waqf Council, Clinic, Concentra, WebMD, Hypertension, Executive, Dignity Health, Smart, Sleep, Sleep deprivation, Fortune 500, Management, Humana

ALPHARETTA, Ga., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Nox Health , a global sleep health leader in sleep diagnostics and value-based sleep care management, today announced the appointment of three new board members: Lloyd Dean, Chief Executive Emeritus & Founding Executive, CommonSpirit Health; David Schlanger, Executive Chairman, Progyny; Dr. Bill Lewis, Telehealth Consultant to Fortune 500 companies.

Key Points: 
  • ALPHARETTA, Ga., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Nox Health , a global sleep health leader in sleep diagnostics and value-based sleep care management, today announced the appointment of three new board members: Lloyd Dean, Chief Executive Emeritus & Founding Executive, CommonSpirit Health; David Schlanger, Executive Chairman, Progyny; Dr. Bill Lewis, Telehealth Consultant to Fortune 500 companies.
  • “Sleep is the missing gap in care central to all chronic conditions,” said Sigurjon Kristjanson, CEO Nox Health.
  • He led CommonSpirit Health and Dignity Health through significant strategic, operational, and financial transformations to its current status as a leading health care organization recognized for high quality, compassionate care, operational excellence and successful financial results.
  • Dr. Bill Lewis commented: “I am proud to join the Board of Directors of Nox Health, a purpose-driven company that is focused on enabling access and improving outcomes, issues that I have dedicated my career to addressing.”

Select Medical Holdings Corporation to Announce Third Quarter 2023 Results on Thursday, November 2, 2023

Retrieved on: 
星期三, 十月 4, 2023
Telephone, Select Medical, Webcast, NYSE, United, Concentra, Hospital

MECHANICSBURG, Pa., Oct. 4, 2023 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its third quarter ended September 30, 2023 on Thursday, November 2, 2023 after the market closes.

Key Points: 
  • MECHANICSBURG, Pa., Oct. 4, 2023 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its third quarter ended September 30, 2023 on Thursday, November 2, 2023 after the market closes.
  • Select Medical will host a conference call regarding its third quarter results, as well as its business outlook, on Friday, November 3, 2023, at 9:00am ET.
  • The conference call will be a live webcast and can be accessed at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com .
  • At June 30, 2023, Select Medical had operations in 46 states and the District of Columbia.

Select Medical Holdings Corporation to Announce Second Quarter 2023 Results on Thursday, August 3, 2023

Retrieved on: 
星期五, 七月 7, 2023
Telephone, Select Medical, Webcast, NYSE, United, Concentra, Hospital

MECHANICSBURG, Pa., July 7, 2023 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its second quarter ended June 30, 2023 on Thursday, August 3, 2023 after the market closes.

Key Points: 
  • MECHANICSBURG, Pa., July 7, 2023 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its second quarter ended June 30, 2023 on Thursday, August 3, 2023 after the market closes.
  • Select Medical will host a conference call regarding its second quarter results, as well as its business outlook, on Friday, August 4, 2023, at 9:00am ET.
  • The conference call will be a live webcast and can be accessed at Select Medical Holdings Corporation's website at www.selectmedicalholdings.com .
  • At March 31, 2023, Select Medical had operations in 46 states and the District of Columbia.